REFERENCES
1. World Health Organization. Laboratory testing for coronavirus disease
2019 (COVID-19) in suspected human cases. 2020;(March):1–7.
2. Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: What we know. Int
J Infect Dis. 2020 May;94:44–8.
3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel
Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med.
2020 Feb;382(8):727–33.
4. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic
characterisation and epidemiology of 2019 novel coronavirus:
implications for virus origins and receptor binding. Lancet. 2020
Feb;395(10224):565–74.
5. World Health Organisation. WHO Coronavirus (COVID-19) Dashboard
| WHO Coronavirus (COVID-19) Dashboard With Vaccination Data
[Internet]. 2022 [cited 2022 Dec 23]. Available from:
https://covid19.who.int/
6. UNICEF Ghana. GHANA COVID-19 Situation Report #19 – June 2021 1.
2021;(June):1–11.
7. Kenu E, Frimpong J, Koram K. Responding to the COVID-19 pandemic in
Ghana. Ghana Med J. 2020 Jun;54(2):72–3.
8. Younes N, Al-Sadeq DW, AL-Jighefee H, Younes S, Al-Jamal O, Daas HI,
et al. Challenges in Laboratory Diagnosis of the Novel Coronavirus
SARS-CoV-2. Viruses [Internet]. 2020 Jun 1 [cited 2022 Dec
23];12(6). Available from: /pmc/articles/PMC7354519/
9. Dinnes J, Sharma P, Berhane S, van Wyk SS, Nyaaba N, Domen J, et al.
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2
infection. Cochrane Database Syst Rev. 2022 Jul 22;2022(7).
10. DIA GREAT. 2019-nCoV Antigen Rapid Test Kit ( Colloidal Gold Assay
). 2022;
11. SD Biosensor. STANDARD Q GH.pdf. 2020.
12. Sure Status. • Quality Management Systems Review and Plan for
Post-Market Surveillance: desk-top review of the manufacturer’s Quality
Management System documentation and specific manufacturing documents.
2021.
13. Brümmer LE, Katzenschlager S, Gaeddert M, Erdmann C, Schmitz S, Bota
M, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A
living systematic review and meta-analysis. Suthar AB, editor. PLOS Med
[Internet]. 2021 Aug 12 [cited 2022 Nov 12];18(8):e1003735.
Available from: https://dx.plos.org/10.1371/journal.pmed.1003735
14. Nalumansi A, Lutalo T, Kayiwa J, Watera C, Balinandi S, Kiconco J,
et al. Field evaluation of the performance of a SARS-CoV-2 antigen rapid
diagnostic test in Uganda using nasopharyngeal samples. Int J Infect
Dis. 2021 Mar;104:282–6.
15. Boum Y, Bebell LM, Bisseck A-CZ-K. Africa needs local solutions to
face the COVID-19 pandemic. Lancet. 2021 Apr;397(10281):1238–40.
16. Abdul-Mumin A, Abubakari A, Agbozo F, Abdul-Karim A, Nuertey BD,
Mumuni K, et al. Field evaluation of specificity and sensitivity of a
standard SARS-CoV-2 antigen rapid diagnostic test: A prospective study
at a teaching hospital in Northern Ghana. Sinha A, editor. PLOS Glob
Public Heal. 2021 Dec;1(12):e0000040.
17. SD BIOSENSOR. STANDARDTM Q COVID-19 Ag Test. 2020;2.
18. Haage V, Ferreira de Oliveira-Filho E, Moreira-Soto A, Kühne A,
Fischer C, Sacks JA, et al. Impaired performance of SARS-CoV-2
antigen-detecting rapid diagnostic tests at elevated and low
temperatures. J Clin Virol. 2021 May;138:104796.
19. Alberg AJ, Park JW, Hager BW, Brock M V., Diener-West M. The use of
“overall accuracy” to evaluate the validity of screening or diagnostic
tests. J Gen Intern Med. 2004;19(5 PART 1):460–5.
20. Aleem S, Zahoor N, Jeelani A. Diagnostic Accuracy of STANDARD Q
COVID-19 Antigen Detection Kit in Comparison with RT-PCR Assay using
Nasopharyngeal Samples in India. 2022;(April 2021):1–5.
21. Ashagre W, Atnafu A, Wassie L, Tschopp R, Fentahun D, Assefa G, et
al. Evaluation of the diagnostic performance of PanbioTM Abbott
SARS-CoV-2 rapid antigen test for the detection of COVID-19 from
suspects attending ALERT center. PLoS One [Internet]. 2022;17(11
November):1–10. Available from:
http://dx.doi.org/10.1371/journal.pone.0277779
22. Arons MM, Hatfield KM, Reddy SC, Kimball A, James A, Jacobs JR, et
al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled
Nursing Facility. N Engl J Med. 2020 May;382(22):2081–90.